bioLytical Laboratories Inc. Announces Health Canada Authorization of its rapid INSTI® HCV Antibody Test for Professional Use in Canada bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Canadian market

bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test bioLytical has received Health Canada authorization to sell its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test across Canada for professional use in point-of-care settingsBy providing results for two...